These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18812454)

  • 21. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
    Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
    Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation.
    Baughman RP; Shipley R; Desai S; Drent M; Judson MA; Costabel U; du Bois RM; Kavuru M; Schlenker-Herceg R; Flavin S; Lo KH; Barnathan ES;
    Chest; 2009 Aug; 136(2):526-535. PubMed ID: 19395578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
    Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
    Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory multisystem sarcoidosis responding to infliximab therapy.
    Croft AP; Situnayake D; Khair O; Giovanni G; Carruthers D; Sivaguru A; Gordon C
    Clin Rheumatol; 2012 Jun; 31(6):1013-8. PubMed ID: 22249374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide for chronic sarcoidosis.
    Baughman RP; Judson MA; Teirstein AS; Moller DR; Lower EE
    Chest; 2002 Jul; 122(1):227-32. PubMed ID: 12114363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory sarcoidosis responding to infliximab.
    Roberts SD; Wilkes DS; Burgett RA; Knox KS
    Chest; 2003 Nov; 124(5):2028-31. PubMed ID: 14605086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nasosinusal and cervical sarcoidosis: a case series of three patients and literature review].
    Hermet M; le Guenno G; Rieu V; Philippe P; Ruivard M
    Rev Med Interne; 2012 Jan; 33(1):46-9. PubMed ID: 21601318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous sarcoid with varied morphology associated with hypercalcaemia and renal impairment.
    Miida H; Ito M
    Clin Exp Dermatol; 2009 Dec; 34(8):e656-9. PubMed ID: 19538188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE;
    Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of lupus pernio with adalimumab.
    Judson MA
    Arch Dermatol; 2011 Nov; 147(11):1332-3. PubMed ID: 22106129
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cutaneous sarcoidosis through a hospital series of 28 cases].
    Ben Jennet S; Benmously R; Chaâbane S; Fenniche S; Marrak H; Mohammed Z; Mokhtar I
    Tunis Med; 2008 May; 86(5):447-50. PubMed ID: 19469298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents.
    Baughman RP; Lower EE
    Am J Clin Dermatol; 2004; 5(6):385-94. PubMed ID: 15663335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of infliximab in treating selected patients with sarcoidosis.
    Saleh S; Ghodsian S; Yakimova V; Henderson J; Sharma OP
    Respir Med; 2006 Nov; 100(11):2053-9. PubMed ID: 16935484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous sarcoidosis.
    Marchell RM; Judson MA
    Semin Respir Crit Care Med; 2010 Aug; 31(4):442-51. PubMed ID: 20665394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.
    Josselin L; Mahr A; Cohen P; Pagnoux C; Guaydier-Souquières G; Hayem G; Job-Deslandre C; Liferman F; Pourrat J; Guillevin L
    Ann Rheum Dis; 2008 Sep; 67(9):1343-6. PubMed ID: 18445626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Besnier-Tennesson lupus pernio].
    Kalamkarian AA; Parastaev SA; Zabanova EV
    Vestn Dermatol Venerol; 1988; (10):16-9. PubMed ID: 3223048
    [No Abstract]   [Full Text] [Related]  

  • 39. Earlobe sarcoidosis.
    Vorselaars AD; Keijsers RG; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):55-7. PubMed ID: 23311125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.
    Baughman RP; Judson MA; Teirstein A; Lower EE; Lo K; Schlenker-Herceg R; Barnathan ES
    Am J Clin Dermatol; 2008; 9(3):155-61. PubMed ID: 18429644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.